Gan & Lee Pharmaceuticals: Product Launch
Gan & Lee Pharmaceuticals achieved positive Phase III clinical trial results for insulin Ludefen (GZR4) in China and Phase III/II positive endpoints for Bofanglutide in weight loss and diabetes treatment programs
Source: PRN — Travel & Hospitality
The leadership read
Will need clinical operations leaders, regulatory affairs specialists, commercial/market access executives, medical affairs directors to manage regulatory submissions and market launch in China and US
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Asia signal share is easing (-2.1pts).
MitchelLake in this thematic
Case study
Executive Search Fintech CPO
Spenmo
Our work · 2019
Chief Technology Officer (CTO)
SEEK Limited
Asia · Technology/Employment Services · technology transformation · regional integration
Our work · 2019
Director Product Engineering
SEEK Limited
Asia · Technology · digital-transformation · cross-border